{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:53:41Z","timestamp":1786974821289,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV 17-30965A"],"award-info":[{"award-number":["AZV 17-30965A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO VFN 64165"],"award-info":[{"award-number":["RVO VFN 64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["Q26\/LF1"],"award-info":[{"award-number":["Q26\/LF1"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["UNCE 204064"],"award-info":[{"award-number":["UNCE 204064"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV260367"],"award-info":[{"award-number":["SVV260367"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Maternally inherited complex I deficiencies due to mutations in <jats:italic>MT-ND<\/jats:italic> genes represent a heterogeneous group of multisystem mitochondrial disorders (MD) with a unfavourable prognosis. The aim of the study was to characterize the impact of the mutations in <jats:italic>MT-ND<\/jats:italic> genes, including the novel m.13091\u2009T\u2009&gt;\u2009C variant, on the course of the disease, and to analyse the activities of respiratory chain complexes, the amount of protein subunits, and the mitochondrial energy-generating system (MEGS) in available muscle biopsies and cultivated fibroblasts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The respiratory chain complex activities were measured by spectrophotometry, MEGS were analysed using radiolabelled substrates, and protein amount by SDS-PAGE or BN-PAGE in muscle or fibroblasts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In our cohort of 106 unrelated families carrying different mtDNA mutations, we found heteroplasmic mutations in the genes <jats:italic>MT-ND1<\/jats:italic>, <jats:italic>MT-ND3<\/jats:italic>, and <jats:italic>MT-ND5<\/jats:italic>, including the novel variant m.13091\u2009T\u2009&gt;\u2009C, in 13 patients with MD from 12 families. First symptoms developed between early childhood and adolescence and progressed to multisystem disease with a phenotype of Leigh or MELAS syndromes. MRI revealed bilateral symmetrical involvement of deep grey matter typical of Leigh syndrome in 6 children, cortical\/white matter stroke-like lesions suggesting MELAS syndrome in 3 patients, and a combination of cortico-subcortical lesions and grey matter involvement in 4 patients. MEGS indicated mitochondrial disturbances in all available muscle samples, as well as a significantly decreased oxidation of [1-<jats:sup>14<\/jats:sup>C] pyruvate in fibroblasts. Spectrophotometric analyses revealed a low activity of complex I and\/or complex I\u2009+\u2009III in all muscle samples except one, but the activities in fibroblasts were mostly normal. No correlation was found between complex I activities and mtDNA mutation load, but higher levels of heteroplasmy were generally found in more severely affected patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Maternally inherited complex I deficiencies were found in 11% of families with mitochondrial diseases in our region. Six patients manifested with Leigh, three with MELAS. The remaining four patients presented with an overlap between these two syndromes. MEGS, especially the oxidation of [1-<jats:sup>14<\/jats:sup>C] pyruvate in fibroblasts might serve as a sensitive indicator of functional impairment due to <jats:italic>MT-ND<\/jats:italic> mutations. Early onset of the disease and higher level of mtDNA heteroplasmy were associated with a worse prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-020-1912-x","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T09:02:33Z","timestamp":1580288553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I"],"prefix":"10.1186","volume":"20","author":[{"given":"Tereza","family":"Danhelovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kolarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hansikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Vaneckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendula","family":"Kucerova-Vidrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Berankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Honzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5141-2289","authenticated-orcid":false,"given":"Marketa","family":"Tesarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"9","key":"1912_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jmedgenet-2012-101159","volume":"49","author":"E Fassone","year":"2012","unstructured":"Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet. 2012;49(9):578\u201390.","journal-title":"J Med Genet"},{"issue":"4","key":"1912_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ajhg.2018.08.013","volume":"103","author":"CL Alston","year":"2018","unstructured":"Alston CL, Heidler J, Dibley MG, Kremer LS, Taylor LS, Fratter C, et al. Bi-allelic mutations in NDUFA6 establish its role in early-onset isolated mitochondrial complex I deficiency. Am J Hum Genet. 2018;103(4):592\u2013601.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1912_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13816810.2015.1092045","volume":"37","author":"H Kolarova","year":"2016","unstructured":"Kolarova H, Liskova P, Tesarova M, Kucerova Vidrova V, Forgac M, Zamecnik J, et al. Unique presentation of LHON\/MELAS overlap syndrome caused by m.13046T>C in MTND5. Ophthalmic Genet. 2016;37(4):419\u201323.","journal-title":"Ophthalmic Genet"},{"key":"1912_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebiom.2018.02.010","volume":"30","author":"YS Ng","year":"2018","unstructured":"Ng YS, Lax NZ, Maddison P, Alston CL, Blakely EL, Hepplewhite PD, et al. MT-ND5 mutation exhibits highly variable neurological manifestations at low mutant load. EBioMedicine. 2018;30:86\u201393.","journal-title":"EBioMedicine."},{"issue":"2","key":"1912_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/19401736.2014.905860","volume":"26","author":"Y Leng","year":"2015","unstructured":"Leng Y, Liu Y, Fang X, Li Y, Yu L, Yuan Y, et al. The mitochondrial DNA 10197 G > a mutation causes MELAS\/Leigh overlap syndrome presenting with acute auditory agnosia. Mitochondrial DNA. 2015;26(2):208\u201312.","journal-title":"Mitochondrial DNA"},{"issue":"7","key":"1912_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/jhg.2012.49","volume":"57","author":"A Vondrackova","year":"2012","unstructured":"Vondrackova A, Vesela K, Hansikova H, Zajicova Docekalova D, Rozsypalova E, Zeman J, et al. High-resolution melting analysis of 15 genes in 60 patients with cytochrome-c oxidase deficiency. J Hum Genet. 2012;57(7):442\u20138.","journal-title":"J Hum Genet"},{"issue":"1","key":"1912_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0003-9861(68)90561-4","volume":"126","author":"MW Makinen","year":"1968","unstructured":"Makinen MW, Lee CP. Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. Arch Biochem Biophys. 1968;126(1):75\u201382.","journal-title":"Arch Biochem Biophys"},{"issue":"Pt. 3","key":"1912_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20040407","volume":"383","author":"P Jesina","year":"2004","unstructured":"Jesina P, Tesarov\u00e1 M, Forn\u016fskov\u00e1 D, Vojt\u00edskov\u00e1 A, Pecina P, Kaplanov\u00e1 V, et al. Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206. Biochem J. 2004;383(Pt. 3):561\u201371.","journal-title":"Biochem J"},{"issue":"1","key":"1912_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0009-8981(94)90055-8","volume":"228","author":"P Rustin","year":"1994","unstructured":"Rustin P, Chretien D, Bourgeron T, G\u00e9rard B, R\u00f6tig A, Saudubray JM, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994;228(1):35\u201351.","journal-title":"Clin Chim Acta"},{"key":"1912_CR10","doi-asserted-by":"crossref","unstructured":"Srere PA. [1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]. In: Lowenstein JM, editor. Methods in Enzymology [Internet]. Academic Press; 1969. p. 3\u201311. (Citric Acid Cycle; vol. 13). Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/0076687969130050. [cited 2015 Apr 5]","DOI":"10.1016\/0076-6879(69)13005-0"},{"issue":"1","key":"1912_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u201375.","journal-title":"J Biol Chem"},{"issue":"2","key":"1912_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0003-2697(91)90094-A","volume":"199","author":"H Sch\u00e4gger","year":"1991","unstructured":"Sch\u00e4gger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem. 1991;199(2):223\u201331.","journal-title":"Anal Biochem"},{"issue":"5","key":"1912_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbadis.2008.02.001","volume":"1782","author":"D Fornuskova","year":"2008","unstructured":"Fornuskova D, Brantova O, Tesarova M, Stiburek L, Honzik T, Wenchich L, et al. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2008;1782(5):317\u201325.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"1912_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","volume":"166","author":"H Sch\u00e4gger","year":"1987","unstructured":"Sch\u00e4gger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987;166(2):368\u201379.","journal-title":"Anal Biochem"},{"issue":"5","key":"1912_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1373\/clinchem.2005.062414","volume":"52","author":"TFJM Janssen","year":"2006","unstructured":"Janssen TFJM, Sengers RCA, Wintjes LTM. Ruitenbeek W, Smeitink JAM, et al. measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin Chem. 2006;52(5):860\u201371.","journal-title":"Clin Chem"},{"issue":"7","key":"1912_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ejhg.2011.18","volume":"19","author":"H Swalwell","year":"2011","unstructured":"Swalwell H, Kirby DM, Blakely EL, Mitchell A, Salemi R, Sugiana C, et al. Respiratory chain complex I deficiency caused by mitochondrial DNA mutations. Eur J Hum Genet. 2011;19(7):769\u201375.","journal-title":"Eur J Hum Genet"},{"issue":"32","key":"1912_CR17","doi-asserted-by":"publisher","first-page":"e11606","DOI":"10.1097\/MD.0000000000011606","volume":"97","author":"Yan-Yan Ma","year":"2018","unstructured":"Ma Y-Y, Li X-Y, Li Z-Q, Song J-Q, Hou J, Li J-H, et al. Clinical, biochemical, and genetic analysis of the mitochondrial respiratory chain complex I deficiency. Medicine (Baltimore). 2018;97(32):e11606.","journal-title":"Medicine"},{"issue":"1","key":"1912_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ana.10435","volume":"53","author":"D Liolitsa","year":"2003","unstructured":"Liolitsa D, Rahman S, Benton S, Carr LJ, Hanna MG. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations? Ann Neurol. 2003;53(1):128\u201332.","journal-title":"Ann Neurol"},{"issue":"3","key":"1912_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/archneurol.2007.67","volume":"65","author":"S Shanske","year":"2008","unstructured":"Shanske S, Coku J, Lu J, Ganesh J, Krishna S, Tanji K, et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol. 2008;65(3):368\u201372.","journal-title":"Arch Neurol"},{"issue":"4","key":"1912_CR20","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1136\/jmg.2006.045716","volume":"44","author":"MJ Blok","year":"2007","unstructured":"Blok MJ, Spruijt L, de Coo IFM, Schoonderwoerd K, Hendrickx A, Smeets HJ. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. J Med Genet. 2007;44(4):e74.","journal-title":"J Med Genet"},{"issue":"2","key":"1912_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10038-003-0116-1","volume":"49","author":"A Sudo","year":"2004","unstructured":"Sudo A, Honzawa S, Nonaka I, Goto Y. Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet. 2004;49(2):92\u20136.","journal-title":"J Hum Genet"},{"issue":"3","key":"1912_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jmg.40.3.188","volume":"40","author":"M Chol","year":"2003","unstructured":"Chol M. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet. 2003;40(3):188\u201391.","journal-title":"J Med Genet"},{"issue":"10","key":"1912_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/jmg.2004.020537","volume":"41","author":"DM Kirby","year":"2004","unstructured":"Kirby DM. Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet. 2004;41(10):784\u20139.","journal-title":"J Med Genet"},{"issue":"2","key":"1912_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/sj.ejhg.5201735","volume":"15","author":"EM Ruiter","year":"2007","unstructured":"Ruiter EM, Siers MH, van den Elzen C, van Engelen BG, Smeitink JAM, Rodenburg RJ, et al. The mitochondrial 13513G > a mutation is most frequent in Leigh syndrome combined with reduced complex I activity, optic atrophy and\/or Wolff-Parkinson-white. Eur J Hum Genet EJHG. 2007;15(2):155\u201361.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"4","key":"1912_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1875-9572(08)60030-3","volume":"49","author":"S-B Wang","year":"2008","unstructured":"Wang S-B, Weng W-C, Lee N-C, Hwu W-L, Fan P-C, Lee W-T. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-white syndrome and cardiomyopathy. Pediatr Neonatol. 2008;49(4):145\u20139.","journal-title":"Pediatr Neonatol"},{"issue":"4","key":"1912_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ymgme.2016.06.003","volume":"118","author":"V Dvorakova","year":"2016","unstructured":"Dvorakova V, Kolarova H, Magner M, Tesarova M, Hansikova H, Zeman J, et al. The phenotypic spectrum of fifty Czech m.3243A>G carriers. Mol Genet Metab. 2016;118(4):288\u201395.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"1912_CR27","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/brain\/aws223","volume":"135","author":"C Tzoulis","year":"2012","unstructured":"Tzoulis C, Bindoff LA. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain. 2012;135(12):3627\u201334.","journal-title":"Brain."},{"issue":"12","key":"1912_CR28","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1161\/01.STR.20.12.1730","volume":"20","author":"LE Knepper","year":"1989","unstructured":"Knepper LE, Biller J, Tranel D, Adams HP, Marsh EE. Etiology of stroke in patients with Wernicke\u2019s aphasia. Stroke. 1989;20(12):1730\u20132.","journal-title":"Stroke."},{"issue":"1","key":"1912_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3348\/kjr.2011.12.1.15","volume":"12","author":"JH Kim","year":"2011","unstructured":"Kim JH, Lim MK, Jeon TY, Rha JH, Rha JH, Eo H, et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol. 2011;12(1):15\u201324.","journal-title":"Korean J Radiol"},{"issue":"5 Suppl","key":"1912_CR30","first-page":"S981","volume":"21","author":"A Napolitano","year":"2000","unstructured":"Napolitano A, Salvetti S, Vista M, Lombardi V, Siciliano G, Giraldi C. Long-term treatment with idebenone and riboflavin in a patient with MELAS. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2000;21(5 Suppl):S981\u20132.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"4","key":"1912_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.braindev.2010.06.010","volume":"33","author":"H Ito","year":"2011","unstructured":"Ito H, Mori K, Kagami S. Neuroimaging of stroke-like episodes in MELAS. Brain and Development. 2011;33(4):283\u20138.","journal-title":"Brain and Development"},{"key":"1912_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 2008;1142:133\u201358.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1912_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1212\/WNL.59.6.816","volume":"59","author":"T Iizuka","year":"2002","unstructured":"Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology. 2002;59(6):816\u201324.","journal-title":"Neurology."},{"issue":"1","key":"1912_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jmg.2010.079624","volume":"48","author":"AS Lebre","year":"2011","unstructured":"Lebre AS, Rio M, Faivre d\u2019Arcier L, Vernerey D, Landrieu P, Slama A, et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet. 2011;48(1):16\u201323.","journal-title":"J Med Genet"},{"issue":"2","key":"1912_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymgme.2004.09.008","volume":"84","author":"T Lerman-Sagie","year":"2005","unstructured":"Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab. 2005;84(2):127\u201336.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"1912_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/NEN.0000000000000195","volume":"74","author":"NJ Lake","year":"2015","unstructured":"Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. J Neuropathol Exp Neurol. 2015;74(6):482\u201392.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1912_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/1971400918786054","volume":"31","author":"J Finsterer","year":"2018","unstructured":"Finsterer J, Zarrouk-Mahjoub S. Cerebral imaging in paediatric mitochondrial disorders. Neuroradiol J. 2018;31(6):596\u2013608.","journal-title":"Neuroradiol J"},{"issue":"3","key":"1912_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/EBC20170109","volume":"62","author":"M Mascalchi","year":"2018","unstructured":"Mascalchi M, Montomoli M, Guerrini R. Neuroimaging in mitochondrial disorders. Essays Biochem. 2018;62(3):409\u201321.","journal-title":"Essays Biochem"},{"issue":"1","key":"1912_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1523\/JNEUROSCI.3430-11.2012","volume":"32","author":"JJ Harris","year":"2012","unstructured":"Harris JJ, Attwell D. The energetics of CNS white matter. J Neurosci. 2012;32(1):356\u201371.","journal-title":"J Neurosci"},{"issue":"7","key":"1912_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1212\/01.WNL.0000080363.10902.E9","volume":"61","author":"V Petruzzella","year":"2003","unstructured":"Petruzzella V, Di Giacinto G, Scacco S, Piemonte F, Torraco A, Carrozzo R, et al. Atypical Leigh syndrome associated with the D393N mutation in the mitochondrial ND5 subunit. Neurology. 2003;61(7):1017\u20138.","journal-title":"Neurology."},{"issue":"1","key":"1912_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T","volume":"49","author":"P Corona","year":"2001","unstructured":"Corona P, Antozzi C, Carrara F, D\u2019Incerti L, Lamantea E, Tiranti V, et al. A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients. Ann Neurol. 2001;49(1):106\u201310.","journal-title":"Ann Neurol"},{"issue":"4","key":"1912_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp.65.4.512","volume":"65","author":"MG Hanna","year":"1998","unstructured":"Hanna MG, Nelson IP, Morgan-Hughes JA, Wood NW. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry. 1998;65(4):512\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1912_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ymgme.2008.04.004","volume":"94","author":"A Brautbar","year":"2008","unstructured":"Brautbar A, Wang J, Abdenur JE, Chang RC, Thomas JA, Grebe TA, et al. The mitochondrial 13513G>a mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab. 2008;94(4):485\u201390.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1912_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.10687","volume":"54","author":"DM Kirby","year":"2003","unstructured":"Kirby DM, Boneh A, Chow CW, Ohtake A, Ryan MT, Thyagarajan D, et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh\u2019s disease. Ann Neurol. 2003;54(4):473\u20138.","journal-title":"Ann Neurol"},{"issue":"3","key":"1912_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2018.01.010","volume":"123","author":"RD Ganetzky","year":"2018","unstructured":"Ganetzky RD, Falk MJ. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease. Mol Genet Metab. 2018;123(3):301\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1912_CR46","doi-asserted-by":"publisher","first-page":"15557","DOI":"10.1038\/s41598-017-15871-y","volume":"7","author":"N Yahata","year":"2017","unstructured":"Yahata N, Matsumoto Y, Omi M, Yamamoto N, Hata R, et al. Sci Rep. 2017;7(1):15557.","journal-title":"Sci Rep"},{"issue":"2","key":"1912_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/BJ20110359","volume":"437","author":"H Angerer","year":"2011","unstructured":"Angerer H, Zwicker K, Wumaier Z, Sokolova L, Heide H, Steger M, et al. A scaffold of accessory subunits links the peripheral arm and the distal proton-pumping module of mitochondrial complex I. Biochem J. 2011;437(2):279\u201388.","journal-title":"Biochem J"},{"issue":"7","key":"1912_CR48","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/brain\/awm114","volume":"130","author":"E Malfatti","year":"2007","unstructured":"Malfatti E, Bugiani M, Invernizzi F, de Souza CF-M, Farina L, Carrara F, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain. 2007;130(7):1894\u2013904.","journal-title":"Brain."},{"issue":"1","key":"1912_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.10787","volume":"55","author":"R McFarland","year":"2004","unstructured":"McFarland R, Kirby DM, Fowler KJ, Ohtake A, Ryan MT, Amor DJ, et al. De novo mutations in the mitochondrialND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann Neurol. 2004;55(1):58\u201364.","journal-title":"Ann Neurol"},{"issue":"32","key":"1912_CR50","doi-asserted-by":"publisher","first-page":"16028","DOI":"10.1073\/pnas.1906896116","volume":"116","author":"PK Kopinski","year":"2019","unstructured":"Kopinski PK, Janssen KA, Schaefer PM, Trefely S, Perry CE, Potluri P, et al. Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy. Proc Natl Acad Sci U S A. 2019;116(32):16028\u201335.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1912_CR51","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ajhg.2008.05.007","volume":"82","author":"SJG Hoefs","year":"2008","unstructured":"Hoefs SJG, Dieteren CEJ, Distelmaier F, Janssen RJRJ, Epplen A, Swarts HGP, et al. NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet. 2008;82(6):1306\u201315.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1912_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.21328","volume":"63","author":"AJM Janssen","year":"2008","unstructured":"Janssen AJM, Schuelke M, Smeitink JAM, Trijbels FJM, Sengers RCA, Lucke B, et al. Muscle 3243A-->G mutation load and capacity of the mitochondrial energy-generating system. Ann Neurol. 2008;63(4):473\u201381.","journal-title":"Ann Neurol"},{"issue":"3","key":"1912_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ejhg.2010.208","volume":"19","author":"P Smits","year":"2011","unstructured":"Smits P, Antonicka H, van Hasselt PM, Weraarpachai W, Haller W, Schreurs M, et al. Mutation in subdomain G\u2019 of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle. Eur J Hum Genet. 2011;19(3):275\u20139.","journal-title":"Eur J Hum Genet"},{"issue":"5\u20136","key":"1912_CR54","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mito.2004.07.039","volume":"4","author":"JM Cameron","year":"2004","unstructured":"Cameron JM, Levandovskiy V, MacKay N, Robinson BH. Respiratory chain analysis of skin fibroblasts in mitochondrial disease. Mitochondrion. 2004;4(5\u20136):387\u201394.","journal-title":"Mitochondrion."},{"issue":"Pt 2","key":"1912_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BST0340217","volume":"34","author":"MS Patel","year":"2006","unstructured":"Patel MS, Korotchkina LG. Regulation of the pyruvate dehydrogenase complex. Biochem Soc Trans. 2006;34(Pt 2):217\u201322.","journal-title":"Biochem Soc Trans"},{"key":"1912_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-2571(01)00061-9","volume":"42","author":"RA Harris","year":"2002","unstructured":"Harris RA, Bowker-Kinley MM, Huang B, Wu P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzym Regul. 2002;42:249\u201359.","journal-title":"Adv Enzym Regul"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-020-1912-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:18:25Z","timestamp":1611793105000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-1912-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1912"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-1912-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the General University Hospital in Prague and was conducted in agreement with institutional guidelines. Written informed consent for participation in the study was obtained from the patients and parents of affected children.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}